David Watson - Dec 19, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
David Watson
Stock symbol
APLS
Transactions as of
Dec 19, 2023
Transactions value $
-$113,988
Form type
4
Date filed
12/20/2023, 04:18 PM
Previous filing
Jul 6, 2023
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $109K +7.91K +9.22% $13.85 93.7K Dec 19, 2023 Direct
transaction APLS Common Stock Sale -$91.5K -1.61K -1.71% $57.00 92.1K Dec 19, 2023 Direct F4
transaction APLS Common Stock Sale -$132K -2.3K -2.5% $57.38 89.8K Dec 19, 2023 Direct F5
holding APLS Common Stock 3.33K Dec 19, 2023 Indirect Owner (Custodial Account for Son) F1
holding APLS Common Stock 80.7K Dec 19, 2023 Indirect Owner (The David O. Watson Irrevocable Trust of 2023) F2
holding APLS Common Stock 6.67K Dec 19, 2023 Indirect Owner (The Watson Education Trust) F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -7.91K -67.76% $0.00 3.76K Dec 19, 2023 Common Stock 7.91K $13.85 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a custodial account held by the reporting person for the sole benefit of his minor son.
F2 The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F3 The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.
F4 This transaction was executed in multiple trades at prices ranging from $56.290 - $57.280. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $57.300 - $57.830. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This option was granted on February 8, 2019 and is fully vested.